BridgeBio Pharma Price to Book Ratio 2018-2023 | BBIO
Historical price to book ratio values for BridgeBio Pharma (BBIO) over the last 10 years. The current price to book ratio for BridgeBio Pharma as of April 26, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| BridgeBio Pharma Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2024-04-26 |
24.88 |
|
0.00 |
| 2023-12-31 |
40.37 |
$-7.67 |
-5.26 |
| 2023-09-30 |
26.37 |
$-6.86 |
-3.84 |
| 2023-06-30 |
17.20 |
$-8.36 |
-2.06 |
| 2023-03-31 |
16.58 |
$-7.56 |
-2.19 |
| 2022-12-31 |
7.62 |
$-8.25 |
-0.92 |
| 2022-09-30 |
9.94 |
$-7.55 |
-1.32 |
| 2022-06-30 |
9.08 |
$-6.84 |
-1.33 |
| 2022-03-31 |
10.15 |
$-7.05 |
-1.44 |
| 2021-12-31 |
16.68 |
$-5.88 |
-2.83 |
| 2021-09-30 |
46.87 |
$-5.02 |
-9.33 |
| 2021-06-30 |
60.96 |
$-3.06 |
-19.94 |
| 2021-03-31 |
61.60 |
$-2.61 |
-23.59 |
| 2020-12-31 |
71.11 |
$0.86 |
82.22 |
| 2020-09-30 |
37.52 |
$1.76 |
21.30 |
| 2020-06-30 |
32.61 |
$2.66 |
12.24 |
| 2020-03-31 |
29.00 |
$3.70 |
7.84 |
| 2019-12-31 |
35.05 |
$3.83 |
9.15 |
| 2019-06-30 |
26.97 |
|
0.00 |
| 2019-09-30 |
21.47 |
$4.45 |
4.83 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$4.375B |
$0.009B |
|
BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.
|
